M. M. de Jong

518 total citations
7 papers, 380 citations indexed

About

M. M. de Jong is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, M. M. de Jong has authored 7 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in M. M. de Jong's work include BRCA gene mutations in cancer (3 papers), Nutrition, Genetics, and Disease (2 papers) and Cancer Genomics and Diagnostics (2 papers). M. M. de Jong is often cited by papers focused on BRCA gene mutations in cancer (3 papers), Nutrition, Genetics, and Disease (2 papers) and Cancer Genomics and Diagnostics (2 papers). M. M. de Jong collaborates with scholars based in Netherlands. M. M. de Jong's co-authors include Gilles Thomas, Edward M. Leter, Nicole C.T. van Grieken, Karin Y. van Spaendonck‐Zwarts, R. Jeroen A. van Moorselaar, Marianne A. Jonker, Maurice A. M. Van Steensel, Fred H. Menko, Theo M. Starink and Pieter E. Postmus and has published in prestigious journals such as Journal of Clinical Oncology, Human Molecular Genetics and British Journal of Cancer.

In The Last Decade

M. M. de Jong

7 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. M. de Jong Netherlands	6	185	177	119	91	74	7	380
Daria Domańska Poland	13	135 0.7×	88 0.5×	63 0.5×	68 0.7×	43 0.6×	18	328
Haruhiko Hirai Japan	8	155 0.8×	98 0.6×	35 0.3×	39 0.4×	54 0.7×	16	337
Anna M. Ray United States	14	192 1.0×	167 0.9×	215 1.8×	81 0.9×	100 1.4×	25	482
Emma J.D. Padilla Australia	11	126 0.7×	122 0.7×	161 1.4×	31 0.3×	48 0.6×	11	335
Pontus Berglund Sweden	9	171 0.9×	132 0.7×	49 0.4×	148 1.6×	71 1.0×	15	414
Jana Soukupová Czechia	12	210 1.1×	200 1.1×	28 0.2×	110 1.2×	112 1.5×	38	467
Chengcheng Ning China	13	154 0.8×	80 0.5×	43 0.4×	94 1.0×	84 1.1×	27	547
Steve McCune United States	10	85 0.5×	44 0.2×	169 1.4×	157 1.7×	79 1.1×	16	326
Truong Lam United States	9	206 1.1×	25 0.1×	74 0.6×	63 0.7×	58 0.8×	16	390
Tarryn Willmer South Africa	10	200 1.1×	49 0.3×	56 0.5×	47 0.5×	50 0.7×	18	300

Countries citing papers authored by M. M. de Jong

Since Specialization

Citations

This map shows the geographic impact of M. M. de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. M. de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. M. de Jong more than expected).

Fields of papers citing papers by M. M. de Jong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. M. de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. M. de Jong. The network helps show where M. M. de Jong may publish in the future.

Co-authorship network of co-authors of M. M. de Jong

This figure shows the co-authorship network connecting the top 25 collaborators of M. M. de Jong. A scholar is included among the top collaborators of M. M. de Jong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. M. de Jong. M. M. de Jong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Hogervorst, Frans B.L., Mary E. Velthuizen, Mariëlle Ruijs, et al.. (2019). TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort. Familial Cancer. 18(2). 273–280. 22 indexed citations

2.

Morreau, Hans, et al.. (2017). Consequences of testing for mismatch repair deficiency of colorectal cancer in clinical practice. Scandinavian Journal of Gastroenterology. 53(5). 632–636. 5 indexed citations

3.

Hartog, Hermien, H. Marike Boezen, M. M. de Jong, et al.. (2013). Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer. The Breast. 22(6). 1155–1160. 28 indexed citations

4.

Houweling, Arjan C., Lieke Gijezen, Marianne A. Jonker, et al.. (2011). Renal cancer and pneumothorax risk in Birt–Hogg–Dubé syndrome; an analysis of 115 FLCN mutation carriers from 35 BHD families. British Journal of Cancer. 105(12). 1912–1919. 118 indexed citations

5.

Jong, M. M. de, Winette T.A. van der Graaf, I Nolte, et al.. (2004). Increased CHEK2 1100delC genotype frequency (also) in unselected breast cancer patients. Journal of Clinical Oncology. 22(14_suppl). 9536–9536. 4 indexed citations

6.

Jong, M. M. de. (2003). The HLA class III subregion is responsible for an increased breast cancer risk. Human Molecular Genetics. 12(18). 2311–2319. 38 indexed citations

7.

Jong, M. M. de, et al.. (2002). Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. Journal of Medical Genetics. 39(4). 225–242. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact